Fate Therapeutics Inc.
- Address
- 12278 Scripps Summit Drive
Sponsor Overview
Specializations
B-cell Mediated Autoimmune Diseases
Fate Therapeutics Inc. focuses on B-cell mediated autoimmune diseases, with research centered on immune-driven conditions in which abnormal B-cell activity contributes to persistent inflammation and tissue damage. Its clinical interest includes therapies aimed at modifying the underlying immune system dysfunction associated with these disorders.
- B-cell-directed immunotherapy
- Autoimmune disease management
- Immune cell modulation
The sponsor’s clinical activity is aligned with developing cell-based immunology approaches for diseases driven by maladaptive B-cell responses.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of FT819 in the Treatment of B-cell Mediated Autoimmune Diseases |  France Sweden | Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 3 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
Partnered Research Centres
3 centres- Address
- 100 Boulevard Du General Leclerc, 92110 Clichy
- Address
- Eugeniavagen 3, 171 64 Solna
- Address
- Akademiska Sjukhuset, 751 85 Uppsala
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Fate Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.